Simplex Trading
GYRE icon

Simplex Trading’s Gyre Therapeutics GYRE Stock Holding History

Simplex Trading’s Portfolio GYRE Stock Details GYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,000
Closed -$13.9K – 9684
2026
Q1 		$13.9K Sell
2,000
-100
-5% -$777 ﹤0.01% 7056
2025
Q4 		$14.8K Buy
+2,100
New +$16.2K ﹤0.01% 6727
2022
Q4 		– Sell
-720
Closed -$2K – 9648
2022
Q3 		$2K Buy
720
+107
+17% +$1.36K ﹤0.01% 9282
2022
Q2 		$8K Buy
+613
New +$4.07K ﹤0.01% 8462
2021
Q2 		– Sell
-60
Closed -$227K – 10273
2021
Q1 		$227K Buy
+60
New +$2.74K ﹤0.01% 4562
2020
Q3 		– Sell
-19
Closed -$82K – 8061
2020
Q2 		$82K Hold
19
– – ﹤0.01% 5004
2020
Q1 		$61K Buy
+19
New +$873 ﹤0.01% 4922
2019
Q4 		– Sell
-8
Closed -$335 – 6967
2019
Q3 		$30K Buy
+8
New +$431 ﹤0.01% 5492
2019
Q2 		– Sell
-13
Closed -$79K – 7371
2019
Q1 		$79K Buy
13
+9
+225% +$578 ﹤0.01% 4592
2018
Q4 		$26K Sell
4
-34
-89% -$2.51K ﹤0.01% 5125
2018
Q3 		$306K Sell
38
-67
-64% -$5.31K ﹤0.01% 3159
2018
Q2 		$917K Buy
105
+39
+59% +$6.84K ﹤0.01% 1878
2018
Q1 		$34K Buy
+66
New +$12.3K ﹤0.01% 2816
2017
Q2 		– Sell
-50
Closed -$130K – 6362
2017
Q1 		$130K Buy
+50
New +$2.92K 0.01% 1524
2015
Q3 		– Hold
0
– -$1K – 5759
2015
Q2 		– Hold
0
– – – 4663
2015
Q1 		– Hold
0
– – – 4481

Other funds holding GYRE

HH
HSG Holding Na, Hong Kong $1.2B AUM 23.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Simplex Trading's GYRE Position: Q2 2026 in Review

Simplex Trading sold out of Gyre Therapeutics (GYRE) in Q2 2026, closing a stake of 674 shares — an estimated $4.7K sold.

Simplex Trading first reported a position in GYRE in Q1 2015 and held it in 18 quarters. The position peaked at $492K in Q2 2018. 60 funds tracked by Wall St. Rank hold GYRE as of Q2 2026.

  • Simplex Trading reported no remaining Gyre Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Simplex Trading sold 674 Gyre Therapeutics shares in Q2 2026, an estimated $4.7K.
  • Simplex Trading first reported a position in Gyre Therapeutics in Q1 2015 and held it in 18 quarters.
  • Simplex Trading's Gyre Therapeutics position peaked at $492K in Q2 2018.
  • 60 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.